PTH and chronic kidney disease: Currently, clinicians can only roughly assess bone abnormalities in CKD patients based on clinical symptoms and commonly used clinical bone metabolism markers, including parathyroid hormone (PTH), vitamin D, phosphorus (P), and calcium (Ca) (7).